The 18th Annual Santa Fe Bone Symposium was held on August 4-5, 2017, in Santa Fe, New Mexico, USA. The symposium convenes health-care providers and clinical
researchers to present and discuss clinical applications of recent advances in research of skeletal diseases. The program includes lectures, oral presentations
by endocrinology fellows, case-based panel discussions, and breakout sessions on topics of interest, with emphasis on participation and interaction
of all participants. Topics included the evaluation and treatment of adult survivors with pediatric bone diseases, risk assessment and management of
atypical femur fractures, nonpharmacologic strategies in the care of osteoporosis, and skeletal effects of parathyroid hormone with opportunities for
therapeutic intervention. Management of skeletal complications of rheumatic diseases was discussed. Insights into sequential and combined use of antiresorptive
agents were presented. Individualization of patient treatment decisions when clinical practice guidelines may not be applicable was covered. Challenges
and opportunities with osteoporosis drug development were discussed. There was an update on progress of Bone Health TeleECHO (Bone Health Extension
for Community Healthcare Outcomes), a teleconferencing strategy for sharing knowledge and expanding capacity to deliver best-practice skeletal health
The presentations are available for viewing at no charge. Begin by clicking the start arrow on each presentation.
PLEASE NOTE THAT CME IS NO LONGER AVAILABLE FOR THIS WEBINAR.
Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis
Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of (1353